EML4-ALK fusion is a genetic alteration that involves the fusion of the EML4 gene with the ALK gene. This fusion leads to the production of a chimeric protein that possesses oncogenic properties, contributing to the development and progression of certain types of cancer, most notably non-small cell lung cancer (NSCLC).
